Publicacións nas que colabora con Juan E. Viñuela Roldán (12)

2021

  1. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

2019

  1. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 5, pp. 6390-6401

2015

  1. CD26 Expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis

    PLoS ONE, Vol. 10, Núm. 7

  2. Erratum: CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis (PLoS ONE (2015) 10:7 (e0131992) (DOI:10.1371/journal.pone.0131992))

    PLoS ONE

2010

  1. Specific inhibition of protein kinase Cβ expression by antisense RNA affects the activation of jurkat T lymphoma cells

    Journal of Biological Regulators and Homeostatic Agents, Vol. 24, Núm. 3, pp. 273-285

2002

  1. Interleukin-dependent modulation of HLA-DR expression on CD4 and CD8 activated T cells

    Immunology and Cell Biology, Vol. 80, Núm. 2, pp. 138-147

2001

  1. Cell surface human α-L-fucosidase

    European Journal of Biochemistry, Vol. 268, Núm. 11, pp. 3321-3331

1999

  1. Prothymosin α antisense oligonucleotides induce apoptosis in HL-60 cells [1]

    Cell Death and Differentiation

1998

  1. Interleukin-12-dependent activation of human lymphocyte subsets

    Immunology Letters, Vol. 61, Núm. 1, pp. 7-13

  2. Overexpression of prothymosin α accelerates proliferation and retards differentiation in HL-60 cells

    Biochemical Journal, Vol. 331, Núm. 3, pp. 753-761

1997

  1. Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes

    Immunobiology, Vol. 197, Núm. 5, pp. 522-533

1994

  1. Interleukin-2 killer cells: In vitro evaluation of combination with prothymosin α

    Lymphokine and Cytokine Research, Vol. 13, Núm. 3, pp. 175-182